Dual-therapy ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
50皮膚筋炎/多発性筋炎1

50. 皮膚筋炎/多発性筋炎


臨床試験数 : 194 薬物数 : 244 - (DrugBank : 89) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 151
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05375435
(ClinicalTrials.gov)
January 1, 202211/5/2022Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive DermatomyositisEfficacy and Safety of Triple Therapy Based on Prognostic Risk Stratification in Patients With Anti-MDA5 Antibody-positive Dermatomyositis: a Multicenter, Prospective, Randomized Controlled StudyDermatomyositis, Adult Type;Interstitial Lung DiseaseDrug: triple therapy;Drug: dual-therapyThe First Affiliated Hospital with Nanjing Medical UniversityNULLRecruiting18 YearsN/AAll120Phase 4China